Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

ClinicalTrials.gov ID: NCT05151731

Public ClinicalTrials.gov record NCT05151731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Double Masked, Active Comparator-Controlled Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients With Diabetic Macular Edema

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of vamikibart administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The duration of the study will be up to 76 weeks.

Study identification

NCT ID
NCT05151731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
394 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2021 (Actual)
Primary completion
Nov 6, 2024 (Actual)
Completion
Apr 21, 2025 (Actual)
Last update posted
May 11, 2026

2021 – 2025

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Win Retina Arcadia California 91006 —
Retina Consultants, San Diego Poway California 92064 —
Retinal Consultants Med Group Sacramento California 95825 —
Bay Area Retina Associates Walnut Creek California 94598 —
Colorado Retina Associates, PC Lakewood Colorado 80228 —
Emerson Clinical Research Institute LLC Washington D.C. District of Columbia 20011-3010 —
Rand Eye Deerfield Beach Florida 33064 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Florida Retina Institute Orlando Florida 32806-1101 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33607 —
Retina Specialists of Tampa Wesley Chapel Florida 33544 —
Butchertown Clinical Trials Louisville Kentucky 40206 —
Cumberland Valley Retina PC Hagerstown Maryland 21740 —
Deep Blue Retina PLLC Southaven Mississippi 38671 —
Sierra Eye Associates Reno Nevada 89502 —
Opthalmic Consultants of LI Lynbrook New York 11563 —
University of Rochester Flaum Eye Institute Rochester New York 14642 —
Western Carolina Retinal Associate PA Asheville North Carolina 28803 —
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 —
Meridian Clinical Research Cincinnati Ohio 45219 —
Verum Research LLC Eugene Oregon 97401 —
EyeHealth Northwest Portland Oregon 97225 —
Erie Retinal Surgery Erie Pennsylvania 16507 —
Eye Care Specialists, PC Kingston Pennsylvania 18704 —
Sewickley Eye Group Sewickley Pennsylvania 15143 —
Charleston Neuroscience Institute Ladson South Carolina 29456 —
Black Hills Eye Institute Rapid City South Dakota 57701 —
Retina Consultants of Nashville Nashville Tennessee 37203 —
Texas Retina Associates Arlington Texas 75075 —
Austin Clinical Research LLC Austin Texas 78750 —
Retina Consultants of Texas Bellaire Texas 77401 —
Valley Retina Institute P.A. McAllen Texas 78503 —
Retina Consultants of Texas The Woodlands Texas 78240 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Wagner Macula & Retina Center Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05151731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05151731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →